Novartis AG

40
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0012005267
CHF
119.14
-0.38 (-0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Novartis AG Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
13,590.00
12,045.00
8,210.00
6,865.00
9,872.00
8,639.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2,541.00
-1,596.00
-1,710.00
-1,499.00
-802.00
-2,560.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
15,898.00
15,516.00
12,992.00
13,596.00
13,778.00
12,812.00
Cash Flow from Investing Activities
-4,050.00
-6,616.00
5,028.00
1,402.00
3,847.00
-12,372.00
Cash Flow from Financing Activities
-12,346.00
-10,340.00
-12,830.00
-19,638.00
-14,869.00
-2,072.00
Net Cash Inflow / Outflow
-19.00
-1,703.00
5,280.00
-4,670.00
2,513.00
-1,364.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
478.00
-262.00
89.00
-30.00
-243.00
268.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CHF Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Novartis AG
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
Profit Before Tax
13590.0768365906
-0.860412445438017
13,590.00
1579583.99%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2541.2878953781
-4.18959001210015
-2,537.00
-60557.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
15898.8285846792
-10.8170152862747
15,908.00
147079.81%
Cash Flow from Investing Activities
-4050.28139403888
46.4200949729942
-4,096.00
-8825.28%
Cash Flow from Financing Activities
-12346.8389348321
-22.919962898411
-12,324.00
-53769.37%
Net Cash Inflow / Outflow
-19.9316697676714
10.843258803129
-29.00
-283.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
478.360074424113
-1.83985798517955
479.00
26099.84%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 2.46% vs 19.42% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
15,898.83
15,516.48
2.46%